Novartis | NVS - Assets

Stock Price
149.86
Daily Change
-1.21 -0.80%
Monthly
8.70%
Yearly
41.99%
Q1 Forecast
145.07

Novartis reported $107.29B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AbbVie USD 133.9B 3.28B Sep/2025
Amgen USD 90.14B 2.24B Sep/2025
AstraZeneca USD 114.46B 2.03B Sep/2025
Bausch Health Companies USD 26.82B 442M Sep/2025
Biogen USD 29.21B 877.3M Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Canopy Growth CAD 1.07B 165.17M Sep/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Drreddys Laboratories INR 6.26B 161.9M Dec/2025
Eli Lilly USD 114.94B 14.01B Sep/2025
Gilead Sciences USD 58.53B 2.81B Sep/2025
GlaxoSmithKline GBP 61.34B 2.08B Sep/2025
Glaxosmithkline GBP 82.45B 23.19B Sep/2025
J&J USD 192.82B 573M Sep/2025
Merck USD 129.55B 12.02B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Pacira USD 1.3B 239.68M Sep/2025
Perrigo USD 10.08B 10.1M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Prestige Brands USD 3.44B 10.66M Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Sanofi EUR 126.81B 25.48B Dec/2025
Supernus Pharmaceuticals USD 1.42B 37.35M Sep/2025
Zoetis USD 15.16B 680M Sep/2025